U
CMD

UBS’s Cantel Medical Corporation CMD Stock Holding History

UBS’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.89M Sell
55,057
-535
-1% -$18.9K ﹤0.01% 2963
2014
Q2 		$2.04M Buy
55,592
+3,176
+6% +$108K ﹤0.01% 2859
2014
Q1 		$1.77M Sell
52,416
-2,840
-5% -$93.7K ﹤0.01% 2903
2013
Q4 		$1.87M Sell
55,256
-1,172
-2% -$40.6K ﹤0.01% 2860
2013
Q3 		$1.8M Sell
56,428
-8,702
-13% -$231K ﹤0.01% 2705
2013
Q2 		$1.47M Buy
+65,130
New +$1.41M ﹤0.01% 2889

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

UBS's CMD Position: Q3 2014 in Review

UBS reduced its Cantel Medical Corporation (CMD) stake by 0.96% in Q3 2014, selling an estimated $18.9K and leaving 55,057 shares worth $1.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2963.

UBS first reported a position in CMD in Q2 2013 and has held it in 6 quarters since. The position peaked at $2.04M in Q2 2014. 155 funds tracked by Wall St. Rank hold CMD as of Q3 2014.

  • UBS held 55,057 shares of Cantel Medical Corporation worth $1.89M as of Q3 2014.
  • UBS sold 535 Cantel Medical Corporation shares in Q3 2014, an estimated $18.9K.
  • Cantel Medical Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2963 holding.
  • UBS first reported a position in Cantel Medical Corporation in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cantel Medical Corporation position peaked at $2.04M in Q2 2014.
  • 155 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.